Cancer gene therapy: challenges and opportunities

Area of Science:

• Molecular medicine and biotechnology
• Therapeutic strategies for human diseases

Background:

• Human disease understanding relies on molecular basis for targeted therapies.
• Cell and protein therapies have historical precedence.
• Gene therapy represents a novel therapeutic frontier.

Purpose of the Study:

• To explore the future trajectory of gene therapy over the next five years.
• To identify key challenges and advancements in gene therapy, particularly for cancer.
• To assess the evolution of gene delivery systems.

Main Methods:

• Review of current gene therapy advancements.
• Analysis of challenges in gene delivery (ex vivo vs. systemic).
• Discussion of viral, non-viral, and nanoparticle vector technologies.

Main Results:

• Delivery of efficacious gene doses to target tissues remains the primary challenge.
• The field is exploring a shift from ex vivo to systemic delivery methods.
• Non-viral vectors and nanoparticles show promise for future gene delivery.

Conclusions:

• Gene therapy's future success hinges on integrating progress from diverse fields like nanotechnology and medical devices.
• Overcoming delivery hurdles is crucial for realizing gene therapy's potential, especially in oncology.
• Continued innovation in vector technology is essential for widespread clinical application.